'Centre to electronically track details of Covid vaccine recipients'
Published By : Prameya News Bureau | November 19, 2020 IST
Share
New Delhi, Nov 19: The Union Health Minister Harsh Vardhan on Thursday informed that the Centre has modified an electronic network to monitor the dosage of Covid vaccines, vaccinators and geographical location of the vaccine recipients.He said that the central government has modified an existing vaccine intelligence network to monitor its appropriate usage and distribution.While speaking at the event organised by women wing of Federation of Indian Chambers of Commerce & Industry (FICCI), Harsh Vardhan said that a meticulous plan is underway to implement the vaccine administration process and in that regard, the government has developed Covid Vaccine Intelligence Network (COVIN)."The vaccine network was already used in universal immunization program. Now, we have modified it to an extent that it could track the dosage of vaccine, its temperature in the storage unit, recipient of the vaccine, and even the time and location when and where the dose administered," the minister said.On the question of prioritisation, Vardhan said that tentative guidelines have been formed to administer the vaccine to priority groups keeping the scientific approach as the ground. He also reiterated that India will procure upto 500 million doses of vaccines by July 2021.The government has divided the prioritization under four groups. The first are healthcare workers, then people above 65 years of age followed by people aged between 50 and 65 and lastly, people below 50 years with underlying conditions."First of all, the priority has been chosen on the basis of scientific and medical grounds. Because we are a country of 135 crore people. For such large numbers of people, nobody can arrange large quantities of doses of vaccines in a single go. Hence, with discussions with the health experts, we have formed the priority groups," Vardhan added.He also hoped that 2021 to be a better year than 2020 for everyone.Currently, five vaccine candidates are currently undergoing clinical trials in India and are in different stages of trials. These include vaccines developed by Oxford University - AstraZeneca, Bharat Biotech, Cadila, Biological E - Baylor College of Medicine and Gamaleya Research Institute, Moscow.Bharat Biotech Ltd and Indian Council for Medical Research (ICMR) began phase-III trials of Covaxin. Serum Institute of India (SII), which inked deal with Oxford-Astrazeneca for manufacturing their vaccine candidate has finished enrolment for Phase-III Covishield vaccine, supported by Indian Council of Medical Research (ICMR).SII has already manufactured 40 million doses of the vaccine, under the at-risk manufacturing and stockpiling license from Drugs Controller General of India (DCGI). Meanwhile, Ahmedabad-based Cadila Healthcare is currently finishing phase-II trials of its vaccine candidate.(IANS)
News7 Is Now On WhatsApp Join And Get Latest News Updates Delivered To You Via WhatsApp
You Might Also Like
More From Related News
ChatGPT unable in assessing heart risk
Plea in SC to examine Covishield side effects
Premature surgical menopause can significantly raise risk of muscle disorders: Study
Loud noise or short exposure may damage inner ear, leading to hearing loss: Study
Benefits of ‘Covishield’ outweigh risks of extremely rare potential side effects: AstraZeneca
AIIMS Bhubaneswar introduces specialized unit for heat stroke patients
Conquering Anxiety: Insights from Psychiatry Prof. Dr. Surjeet Sahoo
SUM Ultimate Medicare (SUMUM) receives JCI prime certification
Know strategies to overcome social anxiety
SUM Hospital conducts Odisha’s first haploidentical hematopoitic stem transplantation
The silent storm: How stress wreaks havoc on your body
More than 5 grams of artificial sweetener saccharin a day can be fatal: Doctors
Low vision clinic inaugurated at AIIMS Bhubaneswar
Loneliness can cause an extreme desire for sugary foods: Study
Experts urge parents to wean children off social media
HK, Singapore food regulators red flag ‘cancer-causing’ ingredient in certain MDH, Everest spices
SUP’ORT training program for physiotherapists held at SUMUM
Patient awareness and interaction programme marks World Liver Day at AIIMS Bhubaneswar
Rising cases of pediatric liver issues linked to junk food epidemic
Vital organ, vital importance: Why maintaining liver health matters